Clinical Trial Update: Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adebrelimab plus chemotherapy and recaticimab as perioperative treatment for resectable non-small cell lung cancer is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Recaticimab (recaticimab)

Snippet

Sponsor: Beijing Chest Hospital, Capital Medical University | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: RECRUITING